D. Schmähl

4.1k total citations · 1 hit paper
153 papers, 3.1k citations indexed

About

D. Schmähl is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, D. Schmähl has authored 153 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Oncology, 33 papers in Molecular Biology and 26 papers in Cancer Research. Recurrent topics in D. Schmähl's work include Carcinogens and Genotoxicity Assessment (16 papers), Lung Cancer Treatments and Mutations (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). D. Schmähl is often cited by papers focused on Carcinogens and Genotoxicity Assessment (16 papers), Lung Cancer Treatments and Mutations (11 papers) and Acute Lymphoblastic Leukemia research (9 papers). D. Schmähl collaborates with scholars based in Germany, Austria and United States. D. Schmähl's co-authors include H. Druckrey, S. Ivanković, R. Preußmann, Martin R. Berger, M. Habs, Bernhard K. Keppler, F. Wingen, H. R. Scherf, Felix T. Garzon and W. Jens Zeller and has published in prestigious journals such as The Lancet, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

D. Schmähl

149 papers receiving 2.8k citations

Hit Papers

[Organotropic carcinogenic effects of 65 various N-nitros... 1967 2026 1986 2006 1967 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Schmähl Germany 25 935 666 629 399 398 153 3.1k
Jerry M. Rice United States 33 1.4k 1.5× 689 1.0× 901 1.4× 608 1.5× 223 0.6× 124 3.8k
D. Schm�hl Germany 20 681 0.7× 260 0.4× 496 0.8× 351 0.9× 277 0.7× 84 2.3k
Joseph P. Brown United States 44 2.7k 2.9× 827 1.2× 669 1.1× 693 1.7× 381 1.0× 116 6.4k
S. Ivanković Germany 34 2.0k 2.2× 560 0.8× 1.3k 2.0× 778 1.9× 516 1.3× 105 5.7k
David E. G. Shuker United Kingdom 31 1.4k 1.5× 242 0.4× 1.2k 1.9× 602 1.5× 186 0.5× 90 3.2k
Charles L. Litterst United States 27 731 0.8× 908 1.4× 296 0.5× 166 0.4× 175 0.4× 71 2.6k
Junko Watanabe Japan 29 1.9k 2.1× 400 0.6× 543 0.9× 211 0.5× 621 1.6× 141 4.6k
C C Winterbourn New Zealand 24 970 1.0× 331 0.5× 195 0.3× 165 0.4× 306 0.8× 32 2.9k
Robert E. Royer United States 35 2.3k 2.5× 750 1.1× 1.6k 2.5× 225 0.6× 368 0.9× 102 5.1k
I Emerit France 34 1.5k 1.6× 249 0.4× 816 1.3× 176 0.4× 177 0.4× 144 3.6k

Countries citing papers authored by D. Schmähl

Since Specialization
Citations

This map shows the geographic impact of D. Schmähl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Schmähl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Schmähl more than expected).

Fields of papers citing papers by D. Schmähl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Schmähl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Schmähl. The network helps show where D. Schmähl may publish in the future.

Co-authorship network of co-authors of D. Schmähl

This figure shows the co-authorship network connecting the top 25 collaborators of D. Schmähl. A scholar is included among the top collaborators of D. Schmähl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Schmähl. D. Schmähl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huober, Jens, Barbara Bertram, Edgar Petru, Manfred Kaufmann, & D. Schmähl. (1991). Metabolism of debrisoquine and susceptibility to breast cancer. Breast Cancer Research and Treatment. 18(1). 43–48. 6 indexed citations
3.
Klenner, T., Bernhard K. Keppler, H. R. Scherf, et al.. (1990). Cisplatin-linked phosphonates in the treatment of the transplantable osteosarcoma in vitro and in vivo. Cancer Treatment Reviews. 17(2-3). 253–259. 48 indexed citations
5.
Berger, Martin R., et al.. (1990). An oestradiol-linked nitrosourea and site-directed chemotherapy in mammary carcinoma. European Journal of Cancer and Clinical Oncology. 26(8). 895–898. 5 indexed citations
6.
Berger, Michael, et al.. (1990). In vitro evaluation of 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl)urea linked to 4-acetoxy-bisdesmethyltamoxifen, estradiol and dihydrotestosterone.. PubMed. 40(5). 603–6. 1 indexed citations
7.
Klenner, T., F. Wingen, Bernhard K. Keppler, B. Krempien, & D. Schmähl. (1990). Anticancer-agent-linked phosphonates with antiosteolytic and antineoplastic properties: a promising perspective in the treatment of bone-related malignancies?. Journal of Cancer Research and Clinical Oncology. 116(4). 341–350. 50 indexed citations
8.
Schmähl, D., et al.. (1990). Implications of the Carcinogenic Hazard of Low Doses of Three Hepatocarcinogenic N‐Nitrosamines1. Japanese Journal of Cancer Research. 81(6-7). 598–606. 7 indexed citations
9.
Petru, Edgar, Martin R. Berger, & D. Schmähl. (1989). Long-term carcinogenicity of cyclophosphamide in two mouse strains with different spontaneous leukemia incidence. Cancer Letters. 44(3). 221–226. 5 indexed citations
10.
Berger, Martin R., et al.. (1989). New estradiol-linked nitrosoureas: Can the pharmacokinetic properties help to explain the pharmacodynamic activities?. European Journal of Cancer and Clinical Oncology. 25(1). 105–111. 9 indexed citations
11.
Schmähl, D., R. Preußmann, & Martin R. Berger. (1989). Causes of cancer — an alternative view to doll and peto (1981). Journal of Molecular Medicine. 67(23). 1169–1173. 4 indexed citations
12.
Schmähl, D., et al.. (1988). Gifte : Geschichte der Toxikologie. Springer eBooks. 6 indexed citations
14.
Berger, Martin R., et al.. (1987). New cytostatics with experimentally different toxic profiles. Cancer Treatment Reviews. 14(3-4). 307–317. 22 indexed citations
15.
Berger, Martin R., D. Schmähl, & Heide Zerban. (1987). Combination experiments with very low doses of three genotoxic N-nitrosamines with similar organotropic carcinogenidty in rats. Carcinogenesis. 8(11). 1635–1643. 46 indexed citations
16.
Friedl, Peter, et al.. (1987). Studies on experimental liver infusion and additional systemic detoxification. Cancer Treatment Reviews. 14(3-4). 247–255. 3 indexed citations
17.
Kaldor, John & D. Schmähl. (1986). Carcinogenicity of alkylating cytostatic drugs : proceedings of a symposium organized by IARC and the German Cancer Research Centre, held at the German Cancer Research Centre, Heidelberg, Federal Republic of Germany, 25-27 November, 1985. 1 indexed citations
18.
Berger, Martin R., P. G. Munder, D. Schmähl, & Otto Westphal. (1984). Influence of the Alkyllysophospholipid ET-18-OCH<sub>3</sub> on Methylnitrosourea-induced Rat Mammary Carcinomas. Oncology. 41(2). 109–113. 32 indexed citations
19.
Lijinsky, W. & D. Schmähl. (1978). Carcinogenesis by nitroso derivatives of methylcarbamate insecticides and other nitrosamides in rats and mice.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 495–501. 8 indexed citations
20.
Scherf, H. R. & D. Schmähl. (1975). Experimental Investigations on Immunodepressive Properties of Carcinogenic Substances in Male Sprague-Dawley Rats. Recent results in cancer research. 76–87. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026